文献速递皮肤肿瘤

转化生长因子β、纤连蛋白与整合素α5β1促进基底细胞癌侵袭

TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.
PubMed 文献 · J Invest Dermatol · 2018-07-14

研究探讨高危浸润性基底细胞癌侵袭机制,发现成纤维细胞、转化生长因子-β和纤连蛋白优先存在于人浸润性基底细胞癌中,并建立体内模型确认转化生长因子-β诱导瘤周纤连蛋白沉积和肿瘤浸润。纤连蛋白通过整合素α5β1介导的黏着斑激酶磷酸化促进基底细胞癌细胞系黏附和迁移,抑制整合素α5β1或磷酸化黏着斑激酶可阻止纤连蛋白诱导的体外迁移和体内浸润。

要点

  • 成纤维细胞、转化生长因子-β和纤连蛋白优先存在于人浸润性基底细胞癌中。
  • 转化生长因子-β诱导瘤周纤连蛋白沉积和肿瘤浸润。
  • 抑制整合素α5β1或磷酸化黏着斑激酶可阻止纤连蛋白诱导的基底细胞癌细胞迁移和浸润。

核心结论

  • 研究结果为了解侵袭性浸润性基底细胞癌的发病机制提供了重要见解,并确定抑制整合素α5β1或黏着斑激酶是治疗晚期基底细胞癌的有前景策略。

研究设计与样本

  • 研究采用人基底细胞癌组织分析、体内模型和基底细胞癌细胞系体外实验,探索高危浸润性基底细胞癌侵袭的分子机制。

主要发现

  • 成纤维细胞、转化生长因子-β和纤连蛋白优先存在于人浸润性基底细胞癌中。
  • 转化生长因子-β诱导瘤周纤连蛋白沉积和肿瘤浸润。
  • 纤连蛋白通过整合素α5β1介导的黏着斑激酶磷酸化促进基底细胞癌细胞系黏附和迁移。
  • 抑制整合素α5β1和磷酸化黏着斑激酶均可阻止纤连蛋白诱导的基底细胞癌细胞体外迁移和体内浸润。

临床怎么用

  • 作者认为抑制整合素α5β1或黏着斑激酶是治疗晚期基底细胞癌的有前景策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Basal cell carcinoma (BCC) is the most frequent human cancer and is becoming an important health problem in an aging population. Based on their clinical and histological characteristics, thick BCC are typically divided into low-risk nodular and high-risk infiltrative subtypes, although the underlying mechanisms are poorly understood. We have identified molecular mechanisms that explain the aggressiveness of high-risk infiltrative BCC, with a potential direct clinical impact. In this study, we first show that fibroblasts, transforming growth factor-β, and fibronectin are found preferentially in infiltrative human BCC. This allowed us to develop in vivo models for the study of infiltrative BCC, which in turn let us confirm the role of transforming growth factor-β in inducing peritumoral fibronectin deposition and tumor infiltration. We then show that fibronectin promotes adhesion and migration of BCC cell lines through integrin α5β1-mediated phosphorylation of focal adhesion kinase. Fittingly, both inhibition of integrin α5β1 and phospho-focal adhesion kinase prevent fibronectin-induced migration of BCC cells in vitro as well as BCC infiltration in vivo. Altogether, our results open important insights into the pathogenesis of aggressive infiltrative BCC and identify integrin α5β1 or focal adhesion kinase inhibition as promising strategies for the treatment of advanced BCC.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Kuonen F, Surbeck I, Sarin KY, et al. TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol. 2018. PMID: 29758283. doi:10.1016/j.jid.2018.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。